How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Get Options quotes for Ginkgo Bioworks Holdings, Inc. (DNA). Calls and Puts. Strike price, bid, ask, volume, open interest. In the money.

For PEGs without left-recursion, the semantics are unchanged. PEGs with left-recursion would not be considered ill-formed. Instead, a left-recursive PEG would have the semantics that it describes the ...